Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Model for alternative RNA processing in human calcitonin gene expression.

R A Bovenberg, W P van de Meerendonk, P D Baas

    Nucleic Acids Research
    |November 25, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Who Is at Risk for Psychological Distress in Genetic Testing Programs for Hereditary Cancer Disorders?

    Journal of genetic counseling·2015
    Same author

    Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines.

    Journal of internal medicine·2004
    Same author

    Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells.

    Endocrine-related cancer·2003
    Same author

    [From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].

    Nederlands tijdschrift voor geneeskunde·2002
    Same author

    [Lump in the neck: 4 patients with a medullary thyroid carcinoma].

    Nederlands tijdschrift voor geneeskunde·2002
    Same author

    Guidelines for diagnosis and therapy of MEN type 1 and type 2.

    The Journal of clinical endocrinology and metabolism·2001

    Investigating human calcitonin gene (CALC-I gene) expression reveals distinct RNA processing pathways. Alternative splicing generates calcitonin (CT) and calcitonin gene-related peptide (CGRP) mRNAs from a common precursor, influencing gene expression in medullary thyroid carcinoma.

    Area of Science:

    • Molecular Biology
    • Gene Expression Regulation
    • RNA Processing

    Background:

    • The human calcitonin gene (CALC-I gene) is known to undergo alternative RNA processing.
    • Understanding these pathways is crucial for comprehending gene expression in conditions like medullary thyroid carcinoma (MTC).
    • Previous studies have identified mature calcitonin (CT) and calcitonin gene-related peptide (CGRP) mRNAs.

    Purpose of the Study:

    • To investigate the alternative RNA processing pathways of the human CALC-I gene.
    • To elucidate the molecular mechanisms leading to the formation of CT and CGRP mRNAs.
    • To correlate RNA processing events with gene expression in MTC.

    Main Methods:

    • Analysis of steady-state RNA isolated from human MTC and a derived cell line.

    Related Experiment Videos

  • Northern blot hybridization using CALC-I gene-specific probes.
  • Identification and characterization of various high molecular weight poly(A)-containing RNAs.
  • Main Results:

    • Detected mature 1.0 Kb CT and 1.1 Kb CGRP mRNAs, along with precursor RNAs (2.1-5.7 Kb).
    • Identified a 5.7 Kb RNA as the primary transcript containing all 6 exons and 5 introns.
    • Delineated a model for alternative splicing, where introns 1, 2, and 5 are removed first, followed by differential splicing and polyadenylation to produce CT or CGRP mRNA from a 3.3 Kb intermediate.

    Conclusions:

    • A sequential splicing and polyadenylation model explains the generation of CT and CGRP mRNAs from the CALC-I gene.
    • The alternative processing pathway involves a common 3.3 Kb intermediate, with subsequent steps determining the final mRNA product.
    • Differences in polyadenylation timing and splice site structures may influence the CT to CGRP mRNA ratio.